Mike Cloughton
Showing 1–5 of 5 transcripts.
- Milken Institute1h 14m
Nasdaq Closing Bell Ceremony | Institute Chairman Michael Milken on Building Meaningful Lives
Michael Milken, Adena Friedman, Michael Klowden, Mike Cloughton, Katie O'Reilly
Adina Friedman of NASDAQ and Michael Milken of the Milken Institute co-hosted a dual-location ceremony in New York and Los Angeles to mark the 20th anniversary of the Global Conference, where Milken introduced a prosperity formula prioritizing technology over physical assets. The event launched the "First 1,000" scholar program to train financial experts in developing nations and highlighted transformative healthcare advancements alongside critical economic challenges like rising obesity and wealth inequality. Milken concluded by calling for a "Sputnik moment" to drive access to capital and innovation, setting the stage for the 2017 conference's focus on building meaningful lives.
- Milken Institute11 min
Lunch Program | Nasdaq Closing Bell Ceremony
Adina Friedman, Mike Cloughton
Marking the 20th anniversary of the Milken Institute Global Conference, Nasdaq President Adina Friedman and Institute Chairman Michael Milken convened over 4,000 global leaders in Los Angeles to advance themes of building meaningful lives and converting ideas into action. The ceremony highlighted the critical role of capital access in driving innovation across healthcare, technology, and job creation, while honoring Milken's influence on medicine and the Nasdaq's history of transforming startups into iconic enterprises like Apple and Tesla. This collaboration underscored the necessity of funding for entrepreneurial growth as experts from finance, government, and medicine gathered to craft solutions for a more productive world.
- Milken Institute1h 10m
Lunch Program | This Changes Everything: How Technology Is Revolutionizing Medicine
Margaret Anderson, Mike Milken, Jack Gilbert, Elizabeth Blackburn, Vadim Bachman, Nina Tandon, Juan Enriquez, Mike Cloughton
Based at the Milken Institute, Faster Cures convenes leading scientists like Dr. Elizabeth Blackburn and Juan Enriquez to advocate for a systemic overhaul of biomedical research that addresses the critical gap between 10,000 known diseases and the 500 treatments currently in development. The event highlights transformative breakthroughs in genomics, microbiome manipulation, and synthetic biology, demonstrating how technologies such as nanocytology and living implants are shifting medical paradigms toward early detection and regenerative solutions. By integrating public policy advocacy with these scientific advancements, the organization aims to optimize the research ecosystem and accelerate the delivery of cures for conditions ranging from cancer to neurodegenerative disorders.
- Milken Institute1h 11m
The Return of Volatility: Canary in the Coal Mine?
Mike Cloughton, Jillian Tett, Alex Friedman, Josh Friedman, Josh Harris, Alan Howard, Kerry Laidrock
Following a panel discussion on market structure, liquidity, and monetary policy, financial experts warn that structural imbalances created by post-2008 regulations and shifting market-maker functions are setting the stage for a structural 10% market pullback within the next four to six months. While the Federal Reserve is expected to delay rate hikes until 2016 due to dovish constraints, investors are advised to bypass overvalued liquid assets in favor of unrated credit, European cyclicals, and Japanese equities to capitalize on mispriced opportunities. The consensus identifies a fundamental market reset as inevitable as central bank support wanes, urging a strategic shift toward unquoted assets and sectors benefiting from geopolitical and commodity shifts to navigate the upcoming volatility.
- Milken Institute1h 7m
Bettering California's Business Climate
Mike Cloughton, Mike Milken, Scott Minard, Kevin DeLeon, Sharon, Troy
Hosted by the Milken Institute, the California Summit convened key policymakers and investors to address the state's economic trajectory, demographic shifts, and innovation capacity. Leaders such as Scott Minard, Senator Kevin de León, and Troy Carter debated strategies to leverage California's upgraded credit rating for massive infrastructure bonds, reform the film tax credit system, and resolve funding disparities for women-led bioscience firms. The event concluded with a consensus that the state must reduce regulatory friction and lower marginal tax rates to retain global talent and sustain growth in critical sectors like technology and healthcare.